Stryker (SYK) Non Operating Income (2009 - 2026)
Stryker (SYK) posted quarterly Non Operating Income of $46.0 million for Q2 2026, down 25.81% year-over-year from $62.0 million in Q2 2025, and down 25.81% on a QoQ basis from $62.0 million in Q1 2026.
Stryker (SYK) Non Operating Income (2009 - 2026) Analysis & Trends
Stryker has reported Non Operating Income for 18 years, with the latest figure at $46.0 million in Q2 2026.
- Non Operating Income for Q2 2026 came in at $46.0 million, down 25.81% year-over-year; the trailing twelve-month figure through Jun 2026 was $510.0 million (up 15.91% YoY), and the FY2025 annual result was $232.0 million, up 9.43% from the prior year.
- Non Operating Income retreated to $46.0 million in Q2 2026, from $62.0 million in the prior quarter.
- Over five years, Non Operating Income peaked at $508.0 million in Q4 2025 and troughed at -$106.0 million in Q3 2025.
- A 5-year average of $46.6 million and a median of -$45.5 million in 2024 frame the typical range for Non Operating Income.
- The largest YoY upside for Non Operating Income was 726.42% in 2023 against a maximum downside of 875.0% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$53.0 million in 2022, then surged by 726.42% to $332.0 million in 2023, then rose by 7.23% to $356.0 million in 2024, then jumped by 42.7% to $508.0 million in 2025, then plunged by 90.94% to $46.0 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $46.0 million in Q2 2026, $62.0 million in Q1 2026, and $508.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 46.00 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | - |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -12.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 508.00 Mn |
| Sep 30, 2025 | -106.00 Mn |
| Jun 30, 2025 | -97.00 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 356.00 Mn |
| Sep 30, 2024 | -42.00 Mn |
| Jun 30, 2024 | -53.00 Mn |
| Mar 31, 2024 | -49.00 Mn |
| Dec 31, 2023 | 332.00 Mn |
| Sep 30, 2023 | -62.00 Mn |
| Jun 30, 2023 | -66.00 Mn |
| Mar 31, 2023 | -56.00 Mn |
| Dec 31, 2022 | -53.00 Mn |
| Sep 30, 2022 | 8.00 Mn |
| Jun 30, 2022 | -52.00 Mn |
| Mar 31, 2022 | -61.00 Mn |
| Dec 31, 2021 | -62.00 Mn |
| Sep 30, 2021 | -79.00 Mn |